STOCK TITAN

[Form 4] PRICE T ROWE GROUP INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

T. Rowe Price (TROW) disclosed an insider transaction on Form 4. A director acquired 2,859 shares of common stock on 10/28/2025 at a reported price of $0.00. After this transaction, the director directly holds 2,859 shares. No derivative securities were reported in the filing.

T. Rowe Price (TROW) ha divulgato un'operazione di insider sul Modulo 4. Un amministratore ha acquistato 2.859 azioni ordinarie il 28/10/2025 a un prezzo riportato di $0,00. Dopo questa operazione, l'amministratore detiene direttamente 2.859 azioni. Nel fascicolo non sono stati riportati strumenti derivati.

T. Rowe Price (TROW) divulgó una operación de insider en el Formulario 4. Un director adquirió 2,859 acciones de acciones comunes el 28/10/2025 a un precio informado de $0.00. Tras esta operación, el director posee directamente 2,859 acciones. No se reportaron valores derivados en la presentación.

T. Rowe Price (TROW) Form 4에서 내부자 거래를 공개했습니다. 한 이사는 2025년 10월 28일 $0.00의 보고된 가격으로 보통주 2,859주를 취득했습니다. 이 거래 후 이사는 직접 2,859주를 보유합니다. 신고서에 파생증권은 보고되지 않았습니다.

T. Rowe Price (TROW) a divulgué une opération d'initié sur le formulaire 4. Un administrateur a acquis 2 859 actions ordinaires le 28/10/2025 à un prix déclaré de 0,00 $. Suite à cette opération, l'administrateur détient directement 2 859 actions. Aucune valeur dérivée n'a été déclarée dans le dossier.

T. Rowe Price (TROW) hat eine Insider-Transaktion im Formular 4 offengelegt. Ein Vorstandsmitglied hat am 28.10.2025 2.859 Stammaktien zu einem angegebenen Preis von 0,00 $ erworben. Nach dieser Transaktion besitzt der Direktor direkt 2.859 Aktien. In der Einreichung wurden keine derivativen Wertpapiere gemeldet.

T. Rowe Price (TROW) كشف عن عملية داخلية في النموذج 4. قام مدير بشراء 2,859 سهماً من الأسهم العادية في 28/10/2025 بسعر مُعلن قدره 0.00 دولار. بعد هذه الصفقة، يملك المدير مباشرة 2,859 سهماً. لم يتم الإبلاغ عن أي أدوات مشتقة في الملف.

Positive
  • None.
Negative
  • None.

T. Rowe Price (TROW) ha divulgato un'operazione di insider sul Modulo 4. Un amministratore ha acquistato 2.859 azioni ordinarie il 28/10/2025 a un prezzo riportato di $0,00. Dopo questa operazione, l'amministratore detiene direttamente 2.859 azioni. Nel fascicolo non sono stati riportati strumenti derivati.

T. Rowe Price (TROW) divulgó una operación de insider en el Formulario 4. Un director adquirió 2,859 acciones de acciones comunes el 28/10/2025 a un precio informado de $0.00. Tras esta operación, el director posee directamente 2,859 acciones. No se reportaron valores derivados en la presentación.

T. Rowe Price (TROW) Form 4에서 내부자 거래를 공개했습니다. 한 이사는 2025년 10월 28일 $0.00의 보고된 가격으로 보통주 2,859주를 취득했습니다. 이 거래 후 이사는 직접 2,859주를 보유합니다. 신고서에 파생증권은 보고되지 않았습니다.

T. Rowe Price (TROW) a divulgué une opération d'initié sur le formulaire 4. Un administrateur a acquis 2 859 actions ordinaires le 28/10/2025 à un prix déclaré de 0,00 $. Suite à cette opération, l'administrateur détient directement 2 859 actions. Aucune valeur dérivée n'a été déclarée dans le dossier.

T. Rowe Price (TROW) hat eine Insider-Transaktion im Formular 4 offengelegt. Ein Vorstandsmitglied hat am 28.10.2025 2.859 Stammaktien zu einem angegebenen Preis von 0,00 $ erworben. Nach dieser Transaktion besitzt der Direktor direkt 2.859 Aktien. In der Einreichung wurden keine derivativen Wertpapiere gemeldet.

T. Rowe Price (TROW) كشف عن عملية داخلية في النموذج 4. قام مدير بشراء 2,859 سهماً من الأسهم العادية في 28/10/2025 بسعر مُعلن قدره 0.00 دولار. بعد هذه الصفقة، يملك المدير مباشرة 2,859 سهماً. لم يتم الإبلاغ عن أي أدوات مشتقة في الملف.

T. Rowe Price (TROW) 在表格4中披露了一笔内部交易。一名董事在2025年10月28日以披露的价格0.00美元购买了2,859股普通股。交易完成后,该董事直接持有2,859股。申报中未披露任何衍生证券。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Verma Richard R.

(Last) (First) (Middle)
1307 POINT STREET

(Street)
BALTIMORE MD 21231

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRICE T ROWE GROUP INC [ TROW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/28/2025 A 2,859 A $0.00 2,859 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Cheryl L. Emory, Assistant Corporate Secretary, POA for Verma, Richard R. 10/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TROW report?

A director acquired 2,859 shares of T. Rowe Price common stock on 10/28/2025.

What was the transaction price for the TROW shares?

The reported price was $0.00 per share.

How many TROW shares does the insider own after the transaction?

The director now directly owns 2,859 shares.

Were any derivative securities reported?

No derivative securities were reported in this filing.

What is the insider’s relationship to TROW?

The reporting person is a Director of T. Rowe Price Group, Inc.
T Rowe Price Grp

NASDAQ:TROW

TROW Rankings

TROW Latest News

TROW Latest SEC Filings

TROW Stock Data

23.06B
215.61M
1.71%
80.59%
4.19%
Asset Management
Investment Advice
Link
United States
BALTIMORE